Sustained Virological Response After Only 5 Weeks Treatment With Daclatasvir/Pegylated Interferon and Ribavirin as Part of a Clinical Trial in a Cirrhotic Human Immunodeficiency Virus (HIV) - Hepatitis C Virus (HCV) Co-Infected Patient With Liver Decompensation During Treatment

Journal of AIDS and HIV Research

doi 10.5897/jahr2015.0329